Zobrazeno 1 - 10
of 223
pro vyhledávání: '"Richard Kellermayer"'
Autor:
Kristen G Valencia Deray, Richard Kellermayer, Alexis C Gomez, Kalyani R Patel, Peace Imani, Seiji Kitagawa, Claire E Bocchini, Alvaro Orjuela
Publikováno v:
SAGE Open Medical Case Reports, Vol 12 (2024)
Malakoplakia is a rare, chronic granulomatous disease that mainly affects the genitourinary system of immunocompromised adults. It is caused by a bactericidal deficit in macrophages and, therefore, the treatment includes antimicrobials that reach hig
Externí odkaz:
https://doaj.org/article/050a7c8b8a064df6951f011095eea945
Autor:
Halee Patel, R. Alan Harris, Justin H. Qian, Numan Oezguen, Ashleigh Watson, Reka G. Szigeti, Stanley Cho, Wenly Ruan, Savini Britto, Antone Opekun, Geoffrey Preidis, Richard Kellermayer
Publikováno v:
Cellular and Molecular Gastroenterology and Hepatology, Vol 17, Iss 6, Pp 1069-1071 (2024)
Externí odkaz:
https://doaj.org/article/4ca5b4c214f54b3d9e3c1bac4558f9a5
Autor:
Qinglong Wu, Prapaporn Boonma, Shyam Badu, Nazli Yalcinkaya, Sik Yu So, Kevin W. Garey, Kent Williams, L. Eugene Arnold, Robert J. Shulman, Richard Kellermayer, Tor C. Savidge
Publikováno v:
npj Biofilms and Microbiomes, Vol 9, Iss 1, Pp 1-13 (2023)
Abstract Fecal microbiota transplantation (FMT) has proven to be an effective treatment for recurrent Clostridioides difficile infection (rCDI) in both adult and pediatric patients. However, as microbiome development is a critical factor in children,
Externí odkaz:
https://doaj.org/article/8b7a58a0d8e749a7b279205e86da31e7
Publikováno v:
F1000Research, Vol 11 (2023)
Background: Patients with Crohn’s disease (CD) have an altered intestinal microbiome, which may facilitate novel diagnostic testing. However, accuracy of microbiome classification models across geographic regions may be limited. Therefore, we sough
Externí odkaz:
https://doaj.org/article/71c4a5eff7274fab8f1f8a181b9264cb
Autor:
Mahesh Krishna, Melinda Engevik, Karen Queliza, Savini Britto, Rajesh Shah, Wenly Ruan, Hongtao Wang, James Versalovic, Richard Kellermayer
Publikováno v:
FASEB BioAdvances, Vol 4, Iss 2, Pp 109-120 (2022)
Abstract The purpose of our experiment was to explore how stochastic (inter‐individual variation) gut microbiome composition may link to inflammatory bowel disease (IBD) susceptibility and guide the development of a perinatal preventative probiotic
Externí odkaz:
https://doaj.org/article/3f453d053cac4a7b8a5c9a8302470a66
Autor:
Suresh Venkateswaran, Hari K Somineni, Varun Kilaru, Seyma Katrinli, Jarod Prince, David T Okou, Jeffrey S Hyams, Lee A Denson, Richard Kellermayer, Greg Gibson, David J Cutler, Alicia K Smith, Subra Kugathasan, Karen N Conneely
Publikováno v:
G3: Genes, Genomes, Genetics, Vol 12, Iss 4 (2022)
AbstractRecently, we identified 1,189 CpG sites whose DNA methylation level in blood associated with Crohn’s disease. Here, we examined associations between DNA methylation and genetic variants to identify methylation quantitative trait loci across
Externí odkaz:
https://doaj.org/article/dc395e1a91ec4b6bb6ee83b782ed4d3a
Publikováno v:
FASEB BioAdvances, Vol 1, Iss 8, Pp 493-497 (2019)
Abstract Inflammatory bowel diseases (IBD: Crohn's disease and ulcerative colitis) are becoming common around the world without a cure. Animal models of colitis have become instrumental in IBD research. The dextran sulfate sodium (DSS) induced murine
Externí odkaz:
https://doaj.org/article/c6593dbc11024d96a0f27ce3927d414f
Autor:
Faith D. Ihekweazu, Tatiana Y. Fofanova, Karen Queliza, Dorottya Nagy-Szakal, Christopher J. Stewart, Melinda A. Engevik, Kristina G. Hulten, Nina Tatevian, David Y. Graham, James Versalovic, Joseph F. Petrosino, Richard Kellermayer
Publikováno v:
Gut Microbes, Vol 10, Iss 4, Pp 504-520 (2019)
Background and aims Bacteriotherapy aimed at addressing dysbiosis may be therapeutic for Inflammatory Bowel Diseases (IBDs). We sought to determine if defined Bacteroides-based bacteriotherapy could be an effective and consistent alternative to fecal
Externí odkaz:
https://doaj.org/article/3befe0b806fb4a3fbb70bcee18830637
Autor:
Reka Szigeti, Richard Kellermayer
Publikováno v:
Therapeutic Advances in Infectious Disease, Vol 8 (2021)
Externí odkaz:
https://doaj.org/article/8bb2170a43ec41df94f13c5df41daabf
Autor:
Emily Garnett, Jayson Pagaduan, Deepthi Rajapakshe, Estella Tam, Richard Kellermayer, Sridevi Devaraj
Publikováno v:
Practical Laboratory Medicine, Vol 22, Iss , Pp e00178- (2020)
Objectives: Inflammatory bowel disease (IBD) is an increasingly prevalent disorder marked by chronic intestinal inflammation. Fecal calprotectin has emerged as a useful biomarker for differential diagnostics and monitoring IBD activity. We validated
Externí odkaz:
https://doaj.org/article/855a380cd9774b598a7687fa3b101004